In this episode, Dr. Douglas Graham, Chief of the Aflac Cancer and Blood Disorders Center, shares progress in pediatric leukemia and sickle cell disease treatments, the impact of a 30-year partnership with Aflac, and breakthroughs in precision medicine, CAR T-cell therapy, and gene therapy that are reshaping outcomes for children and families.
Dr. Douglas Graham, Chief of the Aflac Cancer and Blood Disorders Center
Advertisement
Advertisement
Next Up in Becker's Healthcare Podcast Episodes
-
In this episode, Surendra Khera, MD, MSc, President, Cleveland Clinic Florida Accountable Care Organization; Vice Chief, Primary Care Institute, Florida…
-
In this episode, Larry Lacefield, Force Master Chief (Ret.), U.S. Navy and Healthcare Executive, shares how lessons from military leadership…
-
In this episode, Katie Catlender, Chief Operating Officer at Point32Health, discusses the organization’s push to consolidate legacy digital platforms, reduce…
Join the 500,000+ healthcare executives who start their day with Becker's
Becker's Hospital Review Newsletter is sent Monday–Sunday.
Advertisement
Comments are closed.